Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

Preparing for an FDA Inspection in a Global Pharmaceutical Environment

April 1, 2012

FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.

Growing Your Biopharmaceutical Product Pipeline

April 1, 2012

BioPharm talks with Tarja Mottram, CEO of Action for Results, about key business considerations when starting out.

Meeting Challenges in Contract R&D

March 2, 2012

Representatives from leading CROs weigh in on key challenges tied to the biopharmaceutical R&D, including issues regarding bioequivalence, platform technologies, process analytics, and more.

Empire State Drug Development

March 2, 2012

An architectural wonder teaches the biopharmaceutical industry a valuable lesson in project management.

Considerations in Biopharmaceutical Outsourcing

March 2, 2012

Because of the complexity of the manufacturing processes for biologics, transfer of these processes to a contract manufacturer presents challenges.

FDA Guides the Way to Biosimilars in the US

March 1, 2012

Has the long-awaited guidance answered all of the industry's questions?

Playing the Drug-Development Game

March 1, 2012

Key technical considerations when developing a clinical project in the biotech world.

Putting Risk-Based Decision-Making Where It Belongs

March 1, 2012

Focusing on how risk affects the entire organization can improve the business bottom line.

Communications Advances Present Challenges to Manufacturers

March 1, 2012

Social media use raises questions about applying old standards to new information technology.

ADVERTISEMENT

ADVERTISEMENT

Click here